[ Price : $8.95]
CDER Office of New Drugs director John Jenkins tells RAPS that drug sponsors still dont use the dispute resolution process as much...[ Price : $8.95]
CDER safety policy and communication associate director Paul Seligman says the Center will continue releasing emerging drug safety...[ Price : $8.95]
CDER director Steven Galson announces a new policy for expediting reviews of generic products that meet certain priority criteria....[ Price : $8.95]
FDA approves using Taxotere with cisplatin and fluorouracil for treating head and neck squamous cell carcinoma.[ Price : $8.95]
Ad Age says 18 drug companies placed in the Top 200 advertisers for the first half of 2006 based on their ad spending.[ Price : $8.95]
CDRH director Dan Schultz tells RAPS the agency intends to establish a unique device identifier system for medical devices to redu...[ Price : $8.95]
Consulting editor John Scharmann follows up on responses to his article of measuring compliance, observing that the situation warr...[ Price : $8.95]
CBER director Jesse Goodman says current concerns over terrorism, including bioterrorism, are increasingly occupying the Centers r...